Oncternal Therapeutics, Inc. (ONCT) Financials
ONCT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 36.7 million | 6.7 million |
2023-09-30 | 43.2 million | 6.2 million |
2023-06-30 | 50.8 million | 5.6 million |
2023-03-31 | 58.3 million | 5.8 million |
ONCT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -6.4 million | 2.2 million |
2023-09-30 | -5.5 million | 1.7 million |
2023-06-30 | -9.3 million | 1.7 million |
2023-03-31 | -11.0 million | 1.9 million |
ONCT Net Income
No data available :(
ONCT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 34.3 million | - | 318000 |
2023-09-30 | 40.3 million | - | 342000 |
2023-06-30 | 45.5 million | - | 366000 |
2023-03-31 | 54.3 million | - | 50000 |
ONCT Shares Outstanding
ONCT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 6.7 million | 3.3 million | - |
2023-09-30 | - | 7.5 million | 3.1 million | - |
2023-06-30 | - | 6.6 million | 3.1 million | - |
2023-03-31 | - | 9.0 million | 3.3 million | - |
ONCT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 297000 | - |
2023-09-30 | 179000 | 75000 |
2023-06-30 | 106000 | 37000 |
2023-03-31 | 203000 | 37000 |
ONCT
Price: $8.74
52 week price:
Earnings Per Share: -13.43 USD
P/E Ratio: -0.70
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 91400
Market Capitalization: 25.6 million